CVS Health Corporation $CVS Stock Bought by Hamlin Capital Management LLC

Hamlin Capital Management LLC grew its holdings in CVS Health Corporation (NYSE:CVS) by 13.6% during the third quarter, Holdings Channel.com reports. The firm owned 1,951,402 shares of the pharmacy operator’s stock after buying an additional 233,794 shares during the period. CVS Health comprises about 4.1% of Hamlin Capital Management LLC’s portfolio, making the stock its 12th biggest holding. Hamlin Capital Management LLC’s holdings in CVS Health were worth $167,216,000 at the end of the most recent reporting period.

A number of other institutional investors also recently modified their holdings of CVS. BlackRock Inc. acquired a new stake in shares of CVS Health during the 2nd quarter valued at about $12,747,462,000. State Street Corp raised its position in CVS Health by 26.3% during the second quarter. State Street Corp now owns 74,927,064 shares of the pharmacy operator’s stock valued at $7,751,205,000 after acquiring an additional 15,604,883 shares in the last quarter. Wellington Management Group LLP lifted its stake in CVS Health by 49.8% in the second quarter. Wellington Management Group LLP now owns 33,801,113 shares of the pharmacy operator’s stock valued at $3,496,725,000 after acquiring an additional 11,233,381 shares during the last quarter. Bank of America Corp DE grew its position in CVS Health by 148.0% in the second quarter. Bank of America Corp DE now owns 23,188,670 shares of the pharmacy operator’s stock worth $2,398,868,000 after acquiring an additional 13,836,701 shares in the last quarter. Finally, Pzena Investment Management LLC acquired a new position in shares of CVS Health during the 2nd quarter worth $1,217,558,000. Institutional investors and hedge funds own 80.66% of the company’s stock.

Wall Street Analysts Forecast Growth

CVS has been the subject of several analyst reports. HSBC reaffirmed a “hold” rating and issued a $103.00 price objective on shares of CVS Health in a research note on Monday, July 6th. Sanford C. Bernstein restated an “outperform” rating and set a $112.00 target price on shares of CVS Health in a report on Wednesday, September 9th. Wells Fargo & Company upped their price target on CVS Health from $103.00 to $123.00 and gave the stock an “overweight” rating in a research note on Monday, July 13th. Truist Financial increased their price objective on CVS Health from $108.00 to $118.00 and gave the company a “buy” rating in a report on Tuesday, July 14th. Finally, Bank of America boosted their target price on CVS Health from $100.00 to $110.00 and gave the stock a “buy” rating in a report on Monday, June 22nd. Twenty-two research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $107.24.

More CVS Health News

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: CVS extended pharmaceutical distribution agreements with Cardinal Health and McKesson through 2032. The agreements secure a long-term supply-chain foundation for its retail pharmacies and other dispensing channels, reducing distribution uncertainty. What Does CVS Health Gain From Extending Its Drug Distribution Deals?
• Positive Sentiment: CVS raised its Health Care Benefits outlook as stronger Medicare trends support potential margin recovery, although higher medical costs remain a constraint. This is an important earnings-positive development for Aetna, CVS’s insurance segment. CVS Health Care Benefits Arm Shows Better Core Trends
• Positive Sentiment: Aetna’s 2027 Medicare Advantage plans will be offered in 41 states plus Washington, D.C., with expanded chronic-condition plans and provider-incentive programs. Broader access and care-navigation efforts could support membership and retention. Aetna 2027 Medicare Plans
• Positive Sentiment: CVS opened its first pharmacy-focused location in the Boston area, emphasizing medication access, immunizations and pharmacist-led services. The compact format may help CVS serve targeted markets with a more focused retail footprint. CVS Opens Pharmacy-Focused Boston Location
• Neutral Sentiment: Analysts and financial commentators continue to describe CVS as attractively valued or a potential growth stock, but these views are based largely on valuation models and style rankings rather than new operating results. Why CVS Health Is a Strong Growth Stock
• Negative Sentiment: Investors remain concerned that CVS’s integrated-care strategy could require substantial execution and investment before producing stronger returns. Those concerns may keep the shares below estimated fair value despite their relatively modest valuation. CVS Stock May Trade Below Fair Value

CVS Health Stock Performance

Shares of CVS Health stock traded up $0.32 during trading on Thursday, reaching $88.27. The company’s stock had a trading volume of 2,734,529 shares, compared to its average volume of 8,276,981. CVS Health Corporation has a one year low of $69.51 and a one year high of $110.68. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.66 and a current ratio of 0.87. The firm has a market cap of $112.89 billion, a price-to-earnings ratio of 23.32, a price-to-earnings-growth ratio of 0.84 and a beta of 0.60. The business’s fifty day moving average price is $93.45 and its 200-day moving average price is $92.30.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 EPS for the quarter, topping the consensus estimate of $1.87 by $0.71. CVS Health had a return on equity of 13.12% and a net margin of 1.18%.The company had revenue of $106.10 billion for the quarter, compared to the consensus estimate of $100.03 billion. During the same period in the previous year, the business posted $1.81 EPS. The company’s revenue for the quarter was up 7.3% on a year-over-year basis. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. As a group, equities research analysts predict that CVS Health Corporation will post 8.02 earnings per share for the current year.

CVS Health Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, November 2nd. Shareholders of record on Thursday, October 22nd will be given a $0.6650 dividend. This represents a $2.66 annualized dividend and a yield of 3.0%. The ex-dividend date is Thursday, October 22nd. CVS Health’s dividend payout ratio (DPR) is currently 70.37%.

CVS Health Company Profile

CVS Health Corp. is an integrated health care company that provides pharmacy, insurance and health services primarily in the United States. Its operations are designed to connect consumers, health plans, health care providers and pharmacy services across multiple points of care.

The company’s major businesses include CVS Pharmacy retail locations, prescription fulfillment and consumer health products; CVS Caremark, a pharmacy benefit management business; and Aetna, which offers health insurance products and related services for employers, individuals, government programs and other organizations.